Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-12-065062
Filing Date
2012-11-27
Accepted
2012-11-27 15:46:30
Documents
21
Period of Report
2012-11-27

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT v329259_6k.htm 6-K 2689102
2 GRAPHIC tb1pg2.jpg GRAPHIC 4057
3 GRAPHIC tb2pg1.jpg GRAPHIC 3062
4 GRAPHIC tlogo.jpg GRAPHIC 5355
5 GRAPHIC tb2pg15.jpg GRAPHIC 9707
6 GRAPHIC tb2pg16a.jpg GRAPHIC 5768
7 GRAPHIC tb2pg16b.jpg GRAPHIC 11436
8 GRAPHIC tb2pg16c.jpg GRAPHIC 2108
9 GRAPHIC tb2pg17.jpg GRAPHIC 13129
10 GRAPHIC tb2pg18.jpg GRAPHIC 9448
11 GRAPHIC tb2pg19.jpg GRAPHIC 13213
12 GRAPHIC tb2pg24.jpg GRAPHIC 25940
13 GRAPHIC tb2pg30.jpg GRAPHIC 20065
14 GRAPHIC tb2pg37.jpg GRAPHIC 23064
15 GRAPHIC tb2pg38.jpg GRAPHIC 25014
16 GRAPHIC tb2pg51.jpg GRAPHIC 14839
17 GRAPHIC tb2pg55.jpg GRAPHIC 13792
18 GRAPHIC tb3pg1.jpg GRAPHIC 6520
19 GRAPHIC tb3pg1a.jpg GRAPHIC 9504
20 GRAPHIC t7pg2.jpg GRAPHIC 4305
21 GRAPHIC t8pg2.jpg GRAPHIC 4305
  Complete submission text file 0001144204-12-065062.txt   3002355
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 121226608
SIC: 2834 Pharmaceutical Preparations